
Brian Ngo
Examiner (ID: 19153, Phone: (571)270-7011 , Office: P/2851 )
| Most Active Art Unit | 2851 |
| Art Unit(s) | 2825, 2851 |
| Total Applications | 1288 |
| Issued Applications | 1125 |
| Pending Applications | 69 |
| Abandoned Applications | 122 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20592448
[patent_doc_number] => 12576144
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-17
[patent_title] => Vaccines against Powassan virus, and methods of using same
[patent_app_type] => utility
[patent_app_number] => 17/416199
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 29
[patent_no_of_words] => 13757
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416199
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416199 | Vaccines against Powassan virus, and methods of using same | Dec 19, 2019 | Issued |
Array
(
[id] => 19622921
[patent_doc_number] => 12161713
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Prime-boost vaccination regimen
[patent_app_type] => utility
[patent_app_number] => 17/414187
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 12693
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17414187
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/414187 | Prime-boost vaccination regimen | Dec 18, 2019 | Issued |
Array
(
[id] => 20341918
[patent_doc_number] => 12465633
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Lipopeptide building blocks and synthetic virus-like particles
[patent_app_type] => utility
[patent_app_number] => 17/415305
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12725
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17415305
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/415305 | Lipopeptide building blocks and synthetic virus-like particles | Dec 18, 2019 | Issued |
Array
(
[id] => 16053313
[patent_doc_number] => 20200188511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => METHODS OF IMPROVING EFFICACY OF ALLERGY VACCINES
[patent_app_type] => utility
[patent_app_number] => 16/712605
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12634
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712605
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/712605 | METHODS OF IMPROVING EFFICACY OF ALLERGY VACCINES | Dec 11, 2019 | Abandoned |
Array
(
[id] => 16053301
[patent_doc_number] => 20200188505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => UNIVERSAL INFLUENZA VACCINE
[patent_app_type] => utility
[patent_app_number] => 16/711873
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16711873
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/711873 | Universal influenza vaccine | Dec 11, 2019 | Issued |
Array
(
[id] => 17355433
[patent_doc_number] => 20220016229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => Immunogenic Multiple Hetero-Antigen Polysaccharide-Protein Conjugates and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/312185
[patent_app_country] => US
[patent_app_date] => 2019-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 178362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312185
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/312185 | Immunogenic Multiple Hetero-Antigen Polysaccharide-Protein Conjugates and uses thereof | Dec 8, 2019 | Pending |
Array
(
[id] => 19915214
[patent_doc_number] => 12290560
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-06
[patent_title] => Vaccine for preventing or treating congenital infection with cytomegalovirus
[patent_app_type] => utility
[patent_app_number] => 17/312235
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 4962
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312235
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/312235 | Vaccine for preventing or treating congenital infection with cytomegalovirus | Dec 5, 2019 | Issued |
Array
(
[id] => 15683691
[patent_doc_number] => 20200096509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => METHOD FOR THE DETECTION AND CLASSIFICATION OF PRRSV-INFECTIONS IN SWINE HERDS AND DIAGNOSTIC ANTIGEN COMPOSITIONS FOR SUCH METHODS
[patent_app_type] => utility
[patent_app_number] => 16/706371
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6634
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16706371
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/706371 | METHOD FOR THE DETECTION AND CLASSIFICATION OF PRRSV-INFECTIONS IN SWINE HERDS AND DIAGNOSTIC ANTIGEN COMPOSITIONS FOR SUCH METHODS | Dec 5, 2019 | Abandoned |
Array
(
[id] => 17104578
[patent_doc_number] => 11124777
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => Attenuated porcine sapelovirus strain and immunogenic compositions therefrom
[patent_app_type] => utility
[patent_app_number] => 16/702287
[patent_app_country] => US
[patent_app_date] => 2019-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13116
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16702287
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/702287 | Attenuated porcine sapelovirus strain and immunogenic compositions therefrom | Dec 2, 2019 | Issued |
Array
(
[id] => 16963176
[patent_doc_number] => 20210214675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => Method of Producing High-Strength Composite Sheet Composed of Fiber-Reinforced Grown Biological Matrix
[patent_app_type] => utility
[patent_app_number] => 16/697418
[patent_app_country] => US
[patent_app_date] => 2019-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16697418
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/697418 | Method of Producing High-Strength Composite Sheet Composed of Fiber-Reinforced Grown Biological Matrix | Nov 26, 2019 | Abandoned |
Array
(
[id] => 19808339
[patent_doc_number] => 12239698
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => HIV vaccine immunogens
[patent_app_type] => utility
[patent_app_number] => 17/299852
[patent_app_country] => US
[patent_app_date] => 2019-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 18
[patent_no_of_words] => 26459
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299852 | HIV vaccine immunogens | Nov 26, 2019 | Issued |
Array
(
[id] => 17334672
[patent_doc_number] => 20220001003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS
[patent_app_type] => utility
[patent_app_number] => 17/294706
[patent_app_country] => US
[patent_app_date] => 2019-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17294706
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/294706 | Vaccine for protection against | Nov 21, 2019 | Issued |
Array
(
[id] => 18604880
[patent_doc_number] => 11746334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Adenoviruses and methods for using adenoviruses
[patent_app_type] => utility
[patent_app_number] => 16/690733
[patent_app_country] => US
[patent_app_date] => 2019-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 82
[patent_figures_cnt] => 71
[patent_no_of_words] => 22855
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16690733
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/690733 | Adenoviruses and methods for using adenoviruses | Nov 20, 2019 | Issued |
Array
(
[id] => 15646879
[patent_doc_number] => 20200085969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => PLANT VIRUS PARTICLES FOR DELIVERY OF ANTIMITOTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/688561
[patent_app_country] => US
[patent_app_date] => 2019-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16688561
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/688561 | Plant virus particles for delivery of antimitotic agents | Nov 18, 2019 | Issued |
Array
(
[id] => 17480684
[patent_doc_number] => 20220088188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => PHARMACEUTICAL PREPARATION FOR TREATING HEPATITIS B, PREPARATION METHOD THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/418131
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6679
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17418131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/418131 | Pharmaceutical preparation for treating hepatitis b, preparation method therefor and use thereof | Nov 14, 2019 | Issued |
Array
(
[id] => 17110156
[patent_doc_number] => 20210290753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS IMMUNOGENIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/261055
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17261055
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/261055 | CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS IMMUNOGENIC COMPOSITIONS | Nov 7, 2019 | Abandoned |
Array
(
[id] => 17297857
[patent_doc_number] => 20210393696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => COMPOSITIONS FOR IMPROVING VACCINE SAFETY AND EFFICACY AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/309201
[patent_app_country] => US
[patent_app_date] => 2019-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309201
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309201 | COMPOSITIONS FOR IMPROVING VACCINE SAFETY AND EFFICACY AND METHODS OF USE THEREOF | Nov 5, 2019 | Abandoned |
Array
(
[id] => 19677079
[patent_doc_number] => 12188933
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Tools for detecting cocoa swollen shoot virus coat protein antigen
[patent_app_type] => utility
[patent_app_number] => 17/289850
[patent_app_country] => US
[patent_app_date] => 2019-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 25
[patent_no_of_words] => 8386
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289850
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/289850 | Tools for detecting cocoa swollen shoot virus coat protein antigen | Oct 28, 2019 | Issued |
Array
(
[id] => 19372937
[patent_doc_number] => 12064476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Zika virus immunogenic compositions
[patent_app_type] => utility
[patent_app_number] => 17/287938
[patent_app_country] => US
[patent_app_date] => 2019-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 51
[patent_no_of_words] => 9843
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287938
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/287938 | Zika virus immunogenic compositions | Oct 24, 2019 | Issued |
Array
(
[id] => 17312908
[patent_doc_number] => 20210401956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => VACCINATION AND ANTIBODY GENERATION PLATFORM
[patent_app_type] => utility
[patent_app_number] => 17/288208
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288208
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/288208 | Vsg-based vaccination and antibody generation platform for the treatment of diseases | Oct 23, 2019 | Issued |